#ViksitBharat #HealthcareInnovation #Biotech #SHAKTI #Biopharma #India2047 To view or add a comment, sign in Corealis Pharma Inc
(PubMed) Wang L, Tian Z, Yang Q, et al
Tirzepatide injections target both GLP-1 and GIP pathways for more comprehensive appetite and metabolism support Supports how the body handles fat storage and insulin response, in addition to reducing hunger A once-weekly injection schedule with no daily medication to track or manage A genuine non-surgical weight-loss option with no surgery, no recovery time, and no downtime Can improve blood sugar, cholesterol, and blood pressure, alongside meaningful weight reduction Your Tirzepatide Appointment in Georgetown At Balanced Health & Wellness, weight management medication starts with a real medical evaluation, not a quick intake form, because confirming this is the right option for your specific health profile before anything is prescribed is always the first step
Results vary for each person
2025 | 2:20PM (IST) Manufacturer details 208, Okhla Industrial Estate, Phase-III, New Delhi South Delhi DL 110020 IN Country of origin: INDIA Expiry on or after: December 2026 In case of any issues, contact us: Was this product description useful